The Global Guideline For GCP Audit
ICH GCP has been adopted by three regions and implemented since 1996. The details on GCP auditing are not provided in ICH GCP and there is no global guideline for GCP audit. JSQA thought that the global guideline for GCP audit was necessary to harmonize GCP auditing for the quality assurance of global clinical studies. JSQA looked at ENGAGE (The European Forum for Good Clinical Practice) Auditing Guideline (1998 and 2005), ICH Proposed Guideline for GCP compliance and Quality
System Auditing (1993), ISO 9000 Quality management systems-Fundamentals and vocabulary (2000), ISO 19011 Guidelines for quality and/or environmental management auditing (2002), etc. to get the benefits of them.
JSQA completed the “JSQA Guideline for GCP Auditing” and announced it at 1st GQAC in 2005 as a poster session.
JSQA published “JSQA Guideline for GCP Auditing” on QA Journal of SQA in 2007 (QAJ 403) in order to promote the global discussion for the harmonization of GCP audit.
JSQA proposed the global discussion for Global Guideline for GCP Audit among SQA, BARQA and JSQA in November 2007 at the BARQA annual conference. The global project members were identified and had the kick-off meeting in April 2008 at the 24th SQA annual meeting. The global project members had meetings in October 2008 at 2nd GQAC in Edinburgh and in April 2009 at the 25th SQA annual meeting to discuss the guideline.
This guideline was completed based on the global discussions among SQA, BARQA and JSQA. The guideline includes the mission and the organization of a sponsor’s auditing department and establishes the principles for planning, performing, and reporting audits. The guideline is expected to be a basic principle along with ICH GCP for not only sponsor’s auditors, but also independent auditors and auditors of Contract Research Organizations (CROs) to conduct an audit in the various situations of each country and sponsor.
Table of Contents
1 Scope of the Guideline
3 Mission of a Sponsor’s Auditing Department
4 Auditing Department
4.1 Independent Auditing Department
4.2 Qualified Auditors
4.3 Qualifications of Auditors
4.4 Responsibilities of Auditors
5 Planning of Audits
5.1 Establishing the Goals of an Audit
5.2 Designing and Updating the Audit Plan
5.3 Determining the Subject(s), Timing, and Method(s) of an Audit
5.4 Information in the Audit Plan
6 Conduct of an Audit
6.1 Explaining the Auditing Procedures
6.2 Conducting an Audit and Collecting information
6.3 Confirmation and Evaluation of Audit Observations
7 Reporting the Results of an Audit
7.1 Preparation of an Audit Report
7.2 Persons to whom Audit Reports are submitted
8 Corrective and Preventive Actions
9 Completion of an Audit
10 Audit Certificate
11 Keeping Audit Records
Reviewed and Acknowledged by:
NCT04493996Not yet recruitingIncreasing Preoperative Cognitive Reserve to Prevent Postoperative Cognitive Dysfunction in Cardiac Surgical PatientsConditions: Postoperative Cognitive Decline; Postoperative Delirium; Postoperative Cognitive Dysfunction
NCT04494009Not yet recruitingRandomized Phase II Trial of a PD-1 Inhibitor INCMGA00012 as Consolidation Therapy After Definitive Concurrent Chemoradiotherapy(RHAPSODY)Conditions: Esophageal Cancer
NCT04494022RecruitingConditions: Hepatocellular Carcinoma
NCT04494035RecruitingConditions: Arteriovenous Graft Thrombosis
NCT04494048RecruitingConditions: Obesity; Weight Loss; Gastro Esophageal Reflux; Bariatric Surgery Candidate
NCT04494061Not yet recruitingA Clinical Study to Investigate Interferon Gamma (IFNɣ) Signature in Patients Post HSCT and in Patients With Impaired HSC Proliferation Pre-transplantConditions: Graft Failure
NCT04494074Not yet recruitingConditions: Septic Shock
NCT04494087Not yet recruitingThe Effect of Preoperative Explanatory Videos in Total Extraperitoneal Inguinal Hernioplasty on Information Providing: a Multicenter Randomized Controlled TrialConditions: Inguinal Hernia
NCT04494100Not yet recruitingConditions: Carpal Tunnel Release
NCT04494113Not yet recruitingTesting the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of HysterectomyConditions: Endometrial Serous Adenocarcinoma
Featured Contract Research Organizations
Linical Co., Ltd.
Linical was established in June 2005 by a group of professionals who were engaged in new drug development at a major Japanese pharmaceutical company....
providing wide range of innovative and cost-effective preclinical pharmacology R&D services focusing on but not limited to cardiovascular (infarction,...
MedSource provides support for complex clinical trials with expertise in complex therapeutic areas such as oncology, neurology, and rare diseases and...
Farzan Clinical Research
Farzan Clinical Research is the first Iranian Contract Research Organization (CRO). Our full-service CRO is now an important partner for many Universi...